Ocugen may be able to handle one of the biggest challenges facing vaccine makers.A year ago, Pfizer (NYSE: PFE) and Moderna (NASDAQ: MRNA) were working on bringing their coronavirus vaccine candidates to market. Ocugen (NASDAQ: OCGN) was focusing on something completely different: gene therapy for ...

https://www.fool.com/investing/2021/05/05/can-this-news-push-ocugen-ahead-of-pfizer-moderna/?source=iedfolrf0000001

#fool